Plus Therapeutics (PSTV) Profit After Tax (2011 - 2026)
Plus Therapeutics (PSTV) reported Profit After Tax of -$6.9 million for Q1 2026, up 60.08% year-over-year from -$4.3 million in Q1 2025, and down 22.16% quarter-over-quarter from -$5.7 million in Q4 2025.
Plus Therapeutics (PSTV) Profit After Tax (2011 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has 16 years of Profit After Tax data on file, last reported at -$6.9 million in Q1 2026.
- Profit After Tax for Q1 2026 came in at -$6.9 million, up 60.08% year-over-year; the trailing twelve-month figure through Mar 2026 was -$11.9 million (up 56.1% YoY), and the FY2025 annual result was -$22.4 million, down 72.49% from the prior year.
- Profit After Tax slipped to -$6.9 million in Q1 2026 per PSTV's latest filing, from -$5.7 million in the prior quarter.
- Over five years, Profit After Tax peaked at $5.2 million in Q2 2025 and troughed at -$17.4 million in Q1 2025.
- A 5-year average of -$4.5 million and a median of -$4.1 million in 2022 frame the typical range for Profit After Tax.
- On a YoY basis, Profit After Tax climbed as much as 275.2% in 2025 and fell as far as 433.61% in 2025.
- A 5-year view of Profit After Tax shows it stood at -$5.7 million in 2022, then surged by 32.66% to -$3.8 million in 2023, then fell by 2.44% to -$3.9 million in 2024, then plunged by 45.68% to -$5.7 million in 2025, then dropped by 22.16% to -$6.9 million in 2026.
- Business Quant data shows PSTV's Profit After Tax at -$6.9 million in Q1 2026, -$5.7 million in Q4 2025, and -$4.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -14.46 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -3.63 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -56.74 Mn |
| 10 | Plus Therapeutics | 37.48 Mn | 22.37 Mn | - | -6.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.95 Mn |
| Dec 31, 2025 | -5.69 Mn |
| Sep 30, 2025 | -4.42 Mn |
| Jun 30, 2025 | 5.15 Mn |
| Mar 31, 2025 | -17.40 Mn |
| Dec 31, 2024 | -3.90 Mn |
| Sep 30, 2024 | -2.87 Mn |
| Jun 30, 2024 | -2.94 Mn |
| Mar 31, 2024 | -3.26 Mn |
| Dec 31, 2023 | -3.81 Mn |
| Sep 30, 2023 | -3.22 Mn |
| Jun 30, 2023 | -1.48 Mn |
| Mar 31, 2023 | -4.81 Mn |
| Dec 31, 2022 | -5.66 Mn |
| Sep 30, 2022 | -5.22 Mn |
| Jun 30, 2022 | -5.28 Mn |
| Mar 31, 2022 | -4.12 Mn |
| Dec 31, 2021 | -4.16 Mn |
| Sep 30, 2021 | -3.72 Mn |
| Jun 30, 2021 | -2.80 Mn |